Employing Metagenomics Capture targeted next-generation sequencing for the etiological diagnosis of bloodstream infections
Frontiers in Cellular and Infection Microbiology · 18.08.2026 · 16
DOI: 10.3389/fcimb.2026.1905007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.08.2026. Verfasst von Chuyu Lao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Bacteremia, Sepsis. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bloodstream infections (BSIs) represent a significant public health concern. Metagenomic Capture targeted next-generation sequencing technology, as a newly emerging method for pathogen detection, has been applied in the etiological diagnosis of various infectious diseases and demonstrates good diagnostic efficacy. However, there is relatively limited research on the diagnostic value of this technology for the etiological diagnosis of BSIs.
Methods
A comprehensive retrospective analysis was performed on patients suspected of having BSIs who were admitted to the Affiliated Guangdong Second Provincial General Hospital of Jinan University in 2024. These patients underwent both blood culture analysis and Metagenomic Capture targeted next-generation sequencing technology for diagnostic testing, and a detailed comparison of the results was conducted.
Results
It was found that the Metagenomic Capture-targeted next-generation sequencing method has a shorter time to result [1.33 (1.18 - 1.69) vs 2.73 (1.89 - 3.84) days, p < 0.001], more pathogenic microbial species detected, higher positive detection rate and higher sensitivity than blood culture.
Conclusions
Metagenomic Capture targeted next-generation sequencing technology is a promising tool for pathogen identification in BSIs, offering substantial methodological advantages in terms of turnaround time, detection breadth, and sensitivity. These diagnostic performance characteristics support its potential utility in clinical microbiology practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Infection Prevention and Control, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
- Biosafety Laboratory, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
Zitieren
APA
Lao, C., Li, Z., Lin, G., Li, C., & Wang, Y. (2026). Employing Metagenomics Capture targeted next-generation sequencing for the etiological diagnosis of bloodstream infections. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1905007
Vancouver
Lao C, Li Z, Lin G, Li C, Wang Y. Employing Metagenomics Capture targeted next-generation sequencing for the etiological diagnosis of bloodstream infections. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1905007
BibTeX
@article{Lao2026,
author = {Lao, Chuyu and Li, Zihuan and Lin, Guanwen and Li, Congrong and Wang, Yuqi},
title = {Employing Metagenomics Capture targeted next-generation sequencing for the etiological diagnosis of bloodstream infections},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1905007}
}
EUVIMED